Lunardi Claudio | Department Of Clinical And Experimental Medicine University Of Verona
スポンサーリンク
概要
- LUNARDI Claudioの詳細を見る
- 同名の論文著者
- Department Of Clinical And Experimental Medicine University Of Veronaの論文著者
関連著者
-
LUNARDI Claudio
Department of Clinical and Experimental Medicine, University of Verona
-
CORROCHER Roberto
Department of Clinical and Experimental Medicine, University of Verona
-
Lunardi Claudio
Department Of Clinical And Experimental Medicine University Of Verona
-
PUCCETTI Antonio
Department of Experimental Medicine, University of Genova
-
Corrocher Roberto
Department Of Clinical And Experimental Medicine University Of Verona
-
Puccetti Antonio
Department Of Experimental Medicine University Of Genova
-
Bason Cadetrina
Department Of Clinical And Experimental Medicine University Of Verona
-
Tinazzi Elisa
Department Of Clinical And Experimental Immunology Institute G. Gaslini Largo Girolamo Gaslini
-
Dolcino Marzia
Department Of Clinical And Experimental Immunology Institute G. Gaslini Largo Girolamo Gaslini
-
Rigo Antonella
Department Of Clinical And Experimental Medicine Section Of Hematology University Of Verona
-
Nanni L
Dimes Department Of Experimental Medicine University Of Genova
-
NANNI Luca
DIMES, Department of Experimental Medicine, University of Genova
-
TISO Micaela
CBA/ABC Advanced Diotechnology Center
-
MINGARI Cristina
Department of Clinical and Experimental Oncology
-
BASON Cadetrina
CBA/ABC Advanced Diotechnology Center
-
OLIVERI Mara
DIMES, Department of Experimental Medicine, University of Genova
-
KELLER Beat
Institute of Plant Biology, University of Zurich
-
MILLO Romano
DIMES, Department of Experimental Medicine, University of Genova
-
SANDRE Giorgio
Department of Clinical and Experimental Medicine, University of Verona
-
PUCCETTI Antonio
DIMES, Department of Experimental Medicine, University of Genova
-
Keller Beat
Institute Of Plant Biology University Of Zurich
-
Oliveri Mara
Dimes Department Of Experimental Medicine University Of Genova
-
Millo Romano
Dimes Department Of Experimental Medicine University Of Genova
-
Sandre Giorgio
Department Of Clinical And Experimental Medicine University Of Verona
-
TINAZZI Elisa
Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona
-
PUCCETTI Antonio
Institute G. Gaslini, Department of Immunology
-
GERLI Roberto
Department of Clinical and Experimental Medicine, Section of Rheumatology, University of Perugia
-
MIGLIORINI Paola
Department of Internal Medicine, Section of Clinical Immunology, University of Pisa
-
SIMEONI Sara
Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona
-
BERI Ruggero
Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona
-
DOLCINO Marzia
Institute G. Gaslini, Department of Immunology
-
MARTINELLI Nicola
Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona
-
Beri Ruggero
Department Of Clinical And Experimental Medicine Section Of Internal Medicine University Of Verona
-
Simeoni Sara
Department Of Clinical And Experimental Medicine Section Of Internal Medicine University Of Verona
-
Gerli Roberto
Department Of Clinical And Experimental Medicine Section Of Rheumatology University Of Perugia
-
TRAGGIAI Elisabetta
Department of Clinical and Experimental Immunology, Institute G. Gaslini, Largo Girolamo Gaslini
-
BASON Caterina
Department of Clinical and Experimental Medicine, University of Verona
-
Migliorini Paola
Department Of Internal Medicine Section Of Clinical Immunology University Of Pisa
-
Martinelli Nicola
Department Of Clinical And Experimental Medicine Section Of Internal Medicine University Of Verona
著作論文
- Glycine-rich cell wall proteins act as specific antigen targets in autoimmune and food allergic disorders
- Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE : a possible explanation for the lack of efficacy of hrDNase I treatment
- Generation of anti-NAG-2 mAb from patients' memory B cells : implications for a novel therapeutic strategy in systemic sclerosis